A Retrospective Assessment of Neuropathic Pain in Response to Intraneural Facilitation Therapy and Neurovascular Index-Guided Food Elimination.

: To evaluate the effectiveness of our dual approach in treating neural ischemia. : Researchers were able to retrospectively audit patient data collected from January 2022-September 2024. Patients were included if they received intraneural facilitation (INF), participated in neurovascular index (NVI)-guided food elimination, and completed pre and post pain-quality assessment scale (PQAS) forms in its entirety. : Eighteen of the twenty PQAS descriptive pain variables were significantly different pre- vs. post treatment: intense ( = 0.000), sharp ( = 0.002), hot ( = 0.020), dull ( = 0.022), cold ( = 0.005), sensitive ( = 0.000), shooting ( = 0.000), numb ( = 0.000), electrical ( = 0.000), tingling ( = 0.000), cramping ( = 0.000), radiating ( = 0.000), throbbing ( = 0.000), aching ( = 0.000), heavy ( = 0.000), unpleasant ( = 0.000), deep pain ( = 0.000), and intense surface pain ( = 0.000). Itchy ( = 0.058) and tender ( = 0.062) were not found to be significant. There was also significance in pain decrease in the three mean domains: paroxysmal ( = 0.000), superficial ( = 0.000), and deep ( = 0.000). : This study suggests that blending a mechanical intervention (INF) with a lifestyle modification (NVI-guided food elimination) is effective in improving PQAS scores in patients with peripheral neuropathy, indicating a possible reversal of neural ischemia and maintenance of capillary patency.